Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 22, 2020
Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAEDeeya Gaindh, Yun-Beom Choi, Michelle Marchese, et al.Multiple Sclerosis and Related Disorders|March 20, 2019
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysisStuart Cook, Thomas Leist, Giancarlo Comi, et al.The Lancet. Neurology|March 15, 2011
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysisGavin Giovannoni, Stuart Cook, Kottil Rammohan, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY studyKottil Rammohan, Gavin Giovannoni, Giancarlo Comi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 6, 2017
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY studyGavin Giovannoni, Per Soelberg Sorensen, Stuart Cook, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2018
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY studyGavin Giovannoni, Per Soelberg Sorensen, Stuart Cook, et al.Human Molecular Genetics|February 2, 2002
Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12Emilia Vitale, Stuart Cook, Rong Sun, et al.Multiple Sclerosis and Related Disorders|March 20, 2019
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosisGiancarlo Comi, Stuart Cook, Gavin Giovannoni, et al.Pigment Cell & Melanoma Research|February 7, 2020
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?Abdullah Al Emran, Hsin-Yi Tseng, Mikaela C Coleman, et al.Basic Research in Cardiology|December 1, 2012
Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive ratMassimiliano Mancini, Enrico Petretto, Christina Kleinert, et al.Pageof 6